Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tetrahydroisoquinolines – an updated patent review for cancer treatment (2016 – present)

10 Aug 2024

Abstract excerpt

INTRODUCTION: Cancer is a prominent cause of death globally, triggered by both non-genetic and genetic alterations in genes influenced by various environmental factors. The tetrahydroisoquinoline (THIQ), specifically 1,2,3,4-tetrahydroisoquinoline serves as fundamental element in various alkaloids, prevalent in proximity to quinoline and indole alkaloids. AREA COVERED: In this review, the therapeutic applications...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Berberine and alkaloids research
Share to Synthesis and biological activity

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39126639
DOI: 10.1080/13543776.2024.2391288

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tetrahydroisoquinolines – an updated patent review for cancer treatment (2016 – present)PMID 39126639Read ↗

Isoquinolines alkaloids and cancer metabolism: Pathways and targets to novel chemotherapySemantic proximity Read ↗

Design, synthesis and biological evaluation of new series of hexahydroquinoline and fused quinoline derivatives as potent inhibitors of wild-type EGFR and mutant EGFR (L858R and T790M).Semantic proximity Read ↗

Synthetic and Naturally Occurring Heterocyclic Anticancer Compounds with Multiple Biological TargetsSemantic proximity Read ↗

Flavonoid as possible therapeutic targets against COVID-19: a scoping review of in silico studiesSemantic proximity Read ↗

<i>In silico </i>analysis of multiple targets (HER2 receptor and DNA) inhibition by natural isoquinoline derivatives for breast cancer treatmentSemantic proximity Read ↗

Recruitment of hexahydroquinoline as anticancer scaffold targeting inhibition of wild and mutants EGFR (EGFRWT, EGFRT790M, and EGFRL858R).Semantic proximity Read ↗

Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug DesignSemantic proximity Read ↗

Exploring Anticancer and Antituberculosis Activities of Pt(II) Quinazoline Complexes Derived from EMNEDAQZHO ((E)-2-methyl-3-(1-(naphthalen-1-yl)ethylideneamino)quinazolin-4(3H)-one): Insights and ApplicationsSemantic proximity Read ↗

Indolo[2,3-b]quinoline derivatives as novel promising antitumor agentsSemantic proximity Read ↗

Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug DesignSemantic proximity Read ↗

The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectivesSemantic proximity Read ↗

Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insightsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.